REDCARE PHARMACY INH./ NL0012044747 /
| 15/11/2024 19:32:11 | Chg. -2.80 | Volume | Bid19:50:02 | Ask19:50:02 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 151.30EUR | -1.82% | 250 Turnover: 38,025 |
-Bid Size: - | -Ask Size: - | 2.91 bill.EUR | - | - |
Assets
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 8.3000 | 11.9000 | 13.2000 | 74.5000 | 78.3000 | ||||||
| Intangible Assets | 189.8000 | 199.9000 | 199.9000 | 204.7000 | 257.5000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 2.5000 | 1.7000 | 13.1000 | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 40 | 43.3000 | 56.7000 | 81.2000 | 96.6000 | ||||||
| Accounts Receivable | 20.5000 | 34.6000 | 40.9000 | 44.6000 | 52.3000 | ||||||
| Cash and Cash Equivalents | 15.8000 | 24.3000 | 62.7000 | 90.5000 | 247.4000 | ||||||
| Current Assets | 95.4000 | 136.7000 | 210.8000 | 254.1000 | 432.8000 | ||||||
| Total Assets | 297.8000 | 350.9000 | 428 | 536.9000 | 783.1000 | ||||||
Liabilities
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 23.1000 | 28.4000 | 32 | 53.1000 | 80.5000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 13 | 10.8000 | 3.9000 | 4.3000 | 13.6000 | ||||||
| Liabilities | 58.8000 | 136.9000 | 195.2000 | 111.8000 | 367.7000 | ||||||
| Share Capital | - | - | - | - | - | ||||||
| Total Equity | 239 | 214 | 232.8000 | 425.1000 | 415.4000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 297.8000 | 350.9000 | 428 | 536.9000 | 783.1000 | ||||||
Income Statement
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 284 | 539.7000 | 701 | 968.1000 | 1,060.3000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -19.2000 | -28.7000 | -33.4000 | -.9000 | -65.7000 | ||||||
| Interest Income | -2.1600 | -5.9000 | -8.9000 | -15.1100 | -11.8000 | ||||||
| Income Before Taxes | -21.4000 | -34.6000 | -42.2000 | -15.9000 | -77.9000 | ||||||
| Income Taxes | -.0500 | -1 | -5.9000 | .8000 | 3.7000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -21.4000 | -33.6000 | -36.3000 | -16.8000 | -74.2000 | ||||||
Per Share
Cash Flow
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -23.1000 | -23.5000 | -30.4000 | 17.8000 | 11.6000 | ||||||
| Cash Flow from Investing Activities | -.9000 | -38.1000 | -33.4000 | -40.3000 | -84.3000 | ||||||
| Cash Flow from Financing | -3.5000 | 65.3000 | 102.1000 | 50.3000 | 229.6000 | ||||||
| Decrease / Increase in Cash | -27.6000 | 3.6000 | 38.3000 | 27.8000 | 156.9000 | ||||||
| Employees | 483 | 843 | 1,011 | 1,220 | 1,826 | ||||||
